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Heterogeneity in clinical manifestations is a well-known feature in Long QT Syndrome
(LQTS). The extent of this phenomenon became evident in families wherein both symp-
tomatic and asymptomatic family members are reported. The study hence warrants ge-
netic testing and/or screening of family members of LQTS probands for risk stratification
and prediction.
Of the 46 families screened, 18 probands revealed novel variations/compound hetero-
zygosity in the gene/s screened. Families 1e4 revealed probands carrying novel variations
in KCNQ1 gene along with compound heterozygosity of risk genotypes of the SCN5A, KCNE1
and NPPA gene/s polymorphisms screened. It was also observed that families- 5, 6 and 7
were typical cases of “anticipation” in which both mother and child were diagnosed with
congenital LQTS (cLQTS). Families- 16 and 17 represented aLQTS probands with variations
in IKs and INa encoding genes. First degree relatives (FDRs) carrying the same haplotype as
the proband were also identified which may help in predictive testing and management of
LQTS. Most of the probands exhibiting a family history were found to be genetic com-
pounds which clearly points to the role of cardiac genes and their modifiers in a recessive
fashion in LQTS manifestation.
Copyright © 2015, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
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Long QT Syndrome (LQTS) is associated with prolongation in
ventricular repolarisation and is diagnosed by a prolonged
QTc value exceeding 450 ms and documented syncopal epi-
sodes. However, QTc measurement on electrocardiogram
(ECG) is not always a reliable surrogate marker for prolonged
repolarisation as not all patients who present the LQTS
phenotype exhibit prolonged QTc interval and some asymp-
tomatic individualsmay have prolonged QTc. The detection of
a genetic defect within a family allows for the identification of
all subjects at risk of developing cardiac events. This infor-
mation has a direct impact on the clinical management of
prophylactic therapy for defective gene carriers against fatal
arrhythmias. Hence, a pressing need arises to screen the
LQTS-associated genes for pathologicalmutations in high-risk
individuals [1]. Molecular screening of family members of
probands would unmask many affected relatives, thus
allowing effective preventive measures [2].
Genetic disorders have been associated with carrying
common haplotypes mostly carrying risk alleles. Identifica-
tion of such a common haplotype can be of importance in the
prognostic evaluation of first degree relatives (FDRs). The
Finnish population represents a genetic isolate due to effec-
tive geographical and linguistic separation within the histor-
ical period. The geographical distribution of the birthplaces for
the oldest KCNQ1-Fin carriers closely matches the internal
migration wave commenced from the southeast in the
sixteenth century. The founder gene phenomenon is further
supported by the common haplotype associated with the
disease in virtually all affected individuals examined [3].
Previously, a founderKCNQ1mutation has been reported to
occur in five South African families based on identical
haplotype around the disease locus [1]. Thus, one can envision
not only genotype-specific treatment algorithms but even
mutation-specific considerations. The clinical message is that
in the future attention should be paid to families with a high
percentage of symptomatic individuals and that, once the
disease-causing mutations have been identified, collaborative
studies should be undertaken to test the possibility of identi-
fying other clinically malignant mutations. This will
contribute to the development of a more accurate risk strati-
fication grid for patients affected by LQTS [4].
Considering the previous reports and suggestions,
screening of available family members is warranted in the
present study. Along with controls and patients, the available
family members were also screened for any variations in IKs
(slowly activating delayed rectifier potassium current) and INa
(sodium current) channel encoding genes (already implicated
in LQTS), and single nucleotide polymorphisms of gene/s
which may have a modifying effect on LQTS i.e. beta-
adrenergic receptor-1 & 2 (ADRB 1 & 2), atrial natriuretic pep-
tide (NPPA) and tumor necrosis factor-alpha (TNF-a) gene/s.
The present study on LQTS families is in continuation to our
previous report which revealed mutations in a JLN Syndrome
proband and his family members [5]. In this study, mutations
were identified in three probands and their familymembers. It
was also observed that the probands were carrying more than
one risk allele leading to compound heterozygosity/geneticcompounds. Predictive genetic testing was also carried out for
family members to establish specific haplotype segregating as
in the proband, to identify if the risk of such haplotypes to
LQTS can co-exist in the siblings and first degree relatives
(FDRs) and to predict prognosis of the condition.Methodology
Study subjects
Blood samples were collected for molecular and genetic ana-
lyses from confirmed 46 LQTS probands and 69 first degree
relatives referred to Care Hospitals, Hyderabad, Sri Jayadeva
Institute of Cardiovascular Science and Research, Bangalore,
Institute of Maternal and Child Health, Calicut Medical Col-
lege, Calicut and Krishna Institute of Medical Sciences,
Hyderabad. Samples were collected from 2009 to 2013 due to
the rarity of the disorder. The QTc of the LQTS patients and
their FDRs was confirmed by electrocardiogram. LQTS pa-
tients with prolonged QTc with/without syncope and family
history of sudden cardiac death were included in the study.
Available first degree relatives of the LQTS probands (with/
without any history of cardiovascular disease) were also
included. This study has been approved by the Institutional
Ethics Committee, Dept. of Genetics, Osmania University,
Hyderabad and informed written consent was obtained from
the probands and their available family members. Blood
samples from 150 controls (75 M: 75 F), without any history of
cardiovascular or systemic conditions, was collected from
Osmania General Hospital, Hyderabad for comparative
analysis.
Inclusion and exclusion criteria
Patients who satisfied the diagnostic criteria Schwartz et al.
[24] for LQTS referred by the cardiologists were included in the
study. And cases exhibiting hearing loss other than JLN syn-
drome were excluded.
Molecular analyses
Genomic DNA was isolated from peripheral blood samples by
standard protocols in 150 controls, 46 probands and their
family members. PCR was carried out for all the gene/s
mentioned in a thermal cycler (Eppendorf, Germany) using
specific primers obtained from published reports and muta-
tion database. The primers for KCNQ1, KCNE1 and SCN5Awere
as described by Syrris et al., [6] ADRB1 were by Maqbool et al.
[7] and for ADRB2 by Martinez et al. [8]. NPPA primers used
were as given by Kato et al. [9] For amplification of TNF-alpha
gene 308 G/A SNP, primers sequences from Wu et al. [10]
further modified by Verjans et al. [11] were taken. For
1031 T/C and238 G/A SNPs, primers described by Soga et al.
[12] and Malivanova et al. [13] respectively were used.
For KCNQ1, KCNE1 and SCN5A PCR-SSCP analyses was
carried out on native PAGE gels followed by silver staining.
And for ADRB, NPPA and TNF-a polymorphisms, PCR-RFLP and
ARMS-PCR products were checked on 10% native PAGE gel
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polymorphisms.In-silico analysis
In-silico analysis was carried out to examine the influence of
variations on transmembrane protein structure (http://bioinf.
cs.ucl.ac.uk/psipred/) [14], Tertiary protein structure predic-
tion by RAPTOR-X (http://raptorx.uchicago.edu/) [15] were
elucidated.Results
Family-1
The proband referred as a 6-year old boy was categorized as a
patient of JLN syndrome, a recessive form of Long QT syn-
drome (LQTS) based on the clinical diagnostic criteria with a
history of parental consanguinity, neonatal sibling deaths, age
at onset of 6 months and deafness associated with mutations
in KCNQ1 gene [16,17]. The electropherogram (on repeated
sequencing) of the parents, sibling andmaternal grandmother
revealed a carrier status while the proband harbored recessive
variations. In-silico analysis also revealed the variations may
lead to a change in the secondary structure of mRNA and shift
in the position of splice site. The variations also resulted in a
change of position of the splicing enhancer/inhibitor in KCNQ1
and exonic variations leading to truncated S2eS3 fragment of
KCNQ1 transmembrane protein in cardiac cells with aberrant
repolarization causing prolonged QTc. Apart from this, the
epithelial cells of inner ear are reported to be affected causing
deafness. These variations identified in this proband have
been described in our earlier study [5]. Additional findings of
compound heterozygosity and relatives at risk are being
described in this study.
Compound heterozygosity
Apart from these novel mutations in KCNQ1, the proband also
expressed the risk genotypes e ‘AA’ of KCNE1 S38G, ‘AA’ of
SCN5A H558R and ‘GG’ of SCN5A 98297G > A polymorphisms
identified by SSCP analysis. This compound heterozygosity
may lead to the formation of aberrant INa and IKs channels
leading to prolonged QTc in the proband. The combination of
above reported mutations along with these risk genotypes
may also contribute to severity and disease progressionwhichFig. 1 e Pedigreeis well correlated with a QTc duration of 520 msec and
recurrent syncope.
Relatives at risk
Parents, sibling and maternal grandmother of the proband
were asymptomatic, but their electropherograms revealed
heterozygosity for the variation and the carrier status further
confirms to the recessive inheritance pattern.Family-2
The patient is an 11 day old female neonate. Bradycardia
was detected in the fetus, hence caesarian section was per-
formed but the baby continued to have bradycardia. The
electrocardiogram (ECG) showed a prolonged QTc with a
family history of 2 neonatal deaths and sudden death of
maternal grandfather due to myocardial infarction (Fig. 1).
ECG of the family members was found to be normal. Blood
samples were collected from the proband and her parents.
Molecular results
The PCR-SSCP analysis revealed band pattern variations in the
samples of proband and her mother in exon 15 of KCNQ1 gene
(Fig. 2). Repeated commercial sequencing showed a novel
polymorphism at C338033T in a heterozygous state (Fig. 3)
causing R594X which was confirmed by NCBI BLAST (Fig. 4)
and registered with dbSNP (ss947849412).
In-silico analysis
Since the variation is located in an exon, the protein 3D
structures from RaptorX (Fig. 5) and transmembrane struc-
tures from PSIPRED were compared to the wild type (Fig. 6).
The 3D structures revealed a loss in alpha helix and gain of 2
beta sheets causing changes in conformation of the protein.
Transmembrane structure predictions revealed confor-
mational changes in 3D structure as exon 15 encodes the C-
terminal region of KCNQ1 (Fig. 5).
Compound heterozygosity
In addition to this novel mutation in KCNQ1, the proband also
expressed the risk genotypes e ‘AA’ of KCNQ1 S546S and
IVS13 þ 36A > G, ‘AA’ of SCN5A H558R and ‘GG’ of SCN5A
98297G > A polymorphisms identified by SSCP anlaysis. It can
be hypothesized that the compound heterozygosity observed
may lead to aberrant INa and IKs channels leading to pro-
longed QTc in the proband in a recessive manner.of family-2.
Fig. 2 e SSCP band pattern variations of exon 15 of KCNQ1 gene.
Fig. 3 e Electropherogram showing C338033T.
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The mother of proband was asymptomatic, but the electro-
pherograms revealed the same variation of R594X observed in
the proband in a heterozygous state indicating the potential
risk to mother at a later stage.Fig. 4 e NCBI BLAST Novel Polymorphism atBoth the parents of the proband were found to express the
same haplotype as the proband, increasing the risk to develop
LQTS at later stage (Table 1). This highlights the age related
penetrance of the gene.
Though the proband did not express the trademark
symptoms of syncope and deafness, a prolonged QTc with a
maternal history of two miscarriages and myocardial infarc-
tion inmaternal grandfather was reported. The proband's 7-yr
old sibling and parents were asymptomatic. Molecular
screening by PCR-SSCP analysis revealed band pattern varia-
tion in 15th exon of KCNQ1 gene in proband and her mother
which on commercial sequencing was confirmed as R594X
mutation in a heterozygous state (338033 C/T). This mutation
was found to be present in the C-terminal domain resulting in
modification of 3D structure of the protein. The dominant-
negative effect of this mutation may result in the interaction
of this protein with novel/unknown proteins in the cell lead-
ing to altered interactions of the Kþ channel ending in
bradycardia. Tester et al. [18] reported a similar case on the
prenatal molecular analysis of the amniotic fluid of a fetus at
16 weeks gestation which revealed a mutation in KCNQ1 gene
(LQT1). When bradycardia was detected in the fetus duringC338033T causing R594X (ss947849412).
Fig. 5 e 3D Structure of Wild type and Variant Protein.
Fig. 6 e Transmembrane Structure of Wild-Type and Variant (Exon 15 variations) Protein.
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Genetic testing for congenital long QT syndrome (cLQTS)
would thus become routine due to the inherent risks involved
in amniocentesis [18].
The proband's mother also expressed the same R594X
mutation. Predictive testing revealed that both the parents
were carrying the same haplotype as the proband highlighting
them as potential ‘at risk’ individuals for developing LQTS
correlated to anticipation and age related penetrance of gene.Table 1 e Common haplotype group e risk identification in pr
KCNE1 S38G KCNQ1 S546S KCNQ1 IVS13 þ 36A > G SC
G A AFamily-3
A 32 year old female presented with syncope and prolonged
QTc and no significant family history. Blood samples were
collected from parents, children, siblings and nephews for
molecular analysis (Fig. 7). Molecular analysis revealed band
pattern variations in exon-14 of KCNQ1 gene in proband and
all the family members (parents, children, siblings and
nephews) were subjected to screening (Fig. 8).oband's parents of family-2.
N5A H558R SCN5A 98297G > A Identified in
A G Proband, Mother, Father
Fig. 7 e Pedigree of Family-3.
Fig. 8 e SSCP band pattern variation in proband and family members compared to controls.
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subjected to repeated commercial sequencing. Electrophero-
grams of the amplified samples revealed a heterozygous state
in all the family members and proband (Fig. 9). The hetero-
zygosity in the electropherograms was observed even on
repeated sequencing. This indicates the possibility of an
occurrence of insertions or deletions in the DNA precedingFig. 9 e Electropherogram of proband-3 indicating
heterozygosity in exon-14 of KCNQ1 gene.exon-14. Such heterozygosity may create a dominant-
negative effect leading to truncated KCNQ1 transmembrane
structure.
Compound heterozygosity
Apart from the variation in exon-14 of KCNQ1, the proband
also expressed the risk genotype ‘GG’ of SCN5A 98297G > A
polymorphism identified on SSCP analysis. The compound
heterozygosity observed in the proband may lead to aberrant
electrophysiological properties of the heart causing prolonged
QTc in the proband.
Relatives at risk
Both the parents, children, siblings and nephew-1 of the
proband were also found to harbor the same haplotype as the
proband (Table 2). The electropherograms of exon-14 of
KCNQ1 gene revealed the same variation as observed in the
proband in a heterozygous state indicating the potential risk
to these family members and follow up studies are therefore
warranted in such cases.
KCNQ1 gene screening of proband-3 revealed band pattern
variations in exon-14 which on sequencing revealed a het-
erozygous state. The parents, siblings and children of
proband-3 also exhibited the similar heterozygosity. The
Table 2 e Common haplotype group e risk identification in proband's family members of family-3.
KCNQ1 S546S KCNQ1 IVS13 þ 36A > G SCN5A H558R SCN5A 98297G > A Identified in
A A A G Proband, Mother, Father, children, 3 siblings
and nephew NS1 (son of sister-1)
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and 15 did not reveal any variation, it can be presumed that
this heterozygous state is the result of non-homologous
recombination involving exon-14 due to transposon/
retrotransposons.
The dominant-negative effect of the variation may lead to
the formation of an abnormal Kþ channel which plays a role
in etiology of the disorder by interacting with novel and un-
known protein/s. Since this variation is also detected in the
family members of proband-3, the individuals harboring the
variation/mutation are hence at a potential risk of manifest-
ing the disorder.
Family-4
The proband-4 is a 45 year old female who presented with
syncope and prolonged QTc and a family history of sudden
death of a sibling. Family members were not available for
sample collection (Fig. 10). PCR-SSCP analysis revealed varia-
tion in exon-14 of KCNQ1 gene (Fig. 11). A heteroduplex was
observed in the ds DNA of the SSCP gel.
On repeated commercial sequencing a heterozygous elec-
tropherogram was observed all throughout the amplified
exon-14 of KCNQ1 gene (Fig. 12). It can be hypothesized that
this observed heterozygosity may be the result of non-
homologous recombination involving exon-14 caused by
transposon/retrotransposons or as a result of an indel which
occurred upstream to exon-14.
Compound heterozygosity
The proband also expressed the risk genotype of ‘GG’ of SCN5A
98297G > A polymorphism along with the variation in exon-14
of KCNQ1. The dominant-negative effect due to heterozygosity
in KCNQ1 and the compound heterozygosity leads to prolon-
gation of QTc due to impaired IKs and INa channels. PredictiveFig. 10 e Pedigreetesting in family members is warranted as these variations
may be the reason for family history of sudden death and late
age at onset in the proband.
Family-5
A 12 year old deaf boy presentedwith a history of syncope and
prolonged QTc on electrocardiogram. He had a history of
sudden neonatal death of his twin brother and SCD of another
sibling at the age of 12 years (Fig. 13). The proband was diag-
nosed with cLQTS (JLNS) and administered beta-blockers. The
parents were also subjected to routine check-up which
revealed prolonged QTc in the mother (diagnosed as cLQTS).
The blood samples of the proband and his parents were
collected for molecular analyses.
Compound heterozygosity
Molecular analyses showed compound heterozygosity with
the haplotype comprising of ‘G’ alleles of SCN5A H558R and
G98297A and ‘C’ allele ofNPPA C1364A polymorphisms in both
the cLQTS patients (proband and his mother) (Table 3).
This family is an interesting case of “anticipation”wherein
both the proband and his mother were diagnosed with cLQTS
and the age at onset was 2.5 years in proband and the mother
was diagnosed at a later age of 38 years, with the intensity of
the disorder increasing in generation III with QTc >500 ms in
young proband and sudden cardiac deaths in siblings.
Family-6
Fig. 14 shows a family with both proband and her mother
affected with cLQTS. They presented with prolonged QTc but
no significant family history of sudden deaths. The proband
was a 7 year old female and her 28 year old cLQTS mother.
Blood samples were collected from the proband, her mother,of family-4.
Fig. 12 e Electropherogram showing heterozygosity in
exon-14 of KCNQ1 gene.
Fig. 11 e SSCP band pattern variation in exon-14 of KCNQ1 gene in proband-4.
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year old normal male).
Compound heterozygosity
Molecular analyses revealed that both the probands were
carrying the risk alleles of KCNQ1 S546S and IVS13 þ 36A > G,
SCN5A 98297G > A, and NPPA C1364A. The presence of such
genetic compounds may have lead to impairment of potas-
sium and sodium ion channels leading to prolonged QTc. TheFig. 13 e Pedigreepresence of risk allele of the developmental gene NPPA may
have lead to malfunction during cardiogenesis leading to
congenital LQTS in both the patients.
Relatives at risk
The sibling and maternal uncle were found to carry the same
haplotype as the proband and thus are at a risk of developing
LQTS at a later stage in life depicting age related gene pene-
trance (Table 4). In this family also, the concept of “anticipa-
tion” is clear with the daughter being affected at an earlier age
than the mother.Family-7
This is a unique case wherein a 10 month female proband
and her 38 year old mother were both diagnosed with
cLQTS. The proband's mother had been suffering from epi-
sodes of syncope from 6 years of age and was deaf as a
result of which she was diagnosed as a JLN syndrome pa-
tient (Fig. 15). Her daughter also showed a prolongation
of QTc without deafness and was identified as a cLQTS pa-
tient, and their blood samples were obtained for genetic
analyses.
Compound heterozygosity
The proband andhermotherwere carrying the samehaplotype
represented in Table 5 which included risk alleles for e KCNQ1of Family-5.
Fig. 14 e Pedigree of Family-6.
Table 4 e Common haplotype group e risk identification in proband's family members of family-6.
KCNQ1 S546S KCNQ1 IVS13 þ 36A > G NPPA C1364A SCN5A 98297G > A Identified in
A A C G Proband, Mother (also cLQTS), sibling and maternal uncle
Table 3 e Common haplotype group e risk identification in proband's mother of family-5.
NPPA C1364A SCN5A H558R SCN5A 98297G > A Identified in
C G G Proband, Mother (also LQTS)
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Another interesting finding was the presence of NPPA C1364A
risk allele only in the proband (absent in her mother) which
may have altered cardiogenesis and lead to presentation of
symptoms at an early age. This family represents anticipation
with the mother and daughter being affected. This is also a
classic case of age related penetrance effects.
Family-8
Proband-8 is a 10 year old female who presented with the
symptoms of syncope and prolonged QTc of 530ms. She had a
family history of sudden death of a sibling but no consan-
guinity (Fig. 16). The patient's mother's sample was collected
for analyses.Fig. 15 e PedigreeCompound heterozygosity
The probandwas found to be carrying the risk alleles of SCN5A
H558R and G98297A polymorphisms indicating the role of this
haplotype in the etiology of the disorder.
Relatives at risk
The patient's mother was also found to carry the same
haplotype (Table 6) as the proband which poses the mother at
risk of developing LQTS at a later stage in life.Family-9
Proband-16 is a 50 year old female diagnosed with cLQTS,
presenting with symptoms of syncope and prolonged QTc atof Family-7.
Table 5 e Common haplotype group e risk identification in proband's Mother of family-7.
KCNQ1
S546S
KCNQ1 IVS13þ 36A>G SCN5A
H558R
SCN5A
E1061E
SCN5A
S1074R
SCN5A
98297G > A
NPPA
C1364A
Identified
in
A A G G C G C Proband
A A G G C G heterozygous Mother
Fig. 16 e Pedigree of Family-8.
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were available for genetic analyses.
Compound heterozygosity
The patient was found to carry the risk alleles for e KCNQ1
S546S and IVS13 þ 36A > G, SCN5A H558R and 98297G > A
polymorphisms. The effect of these risk alleles may alter the
functioning of the potassium and sodium ion channels.Family-10
The proband is a 20 year oldmale diagnosed with cLQTS and a
prolonged QTc of 540 ms presenting with symptoms of syn-
cope from the age of 9 years. He had a significant family his-
tory of 4 sudden cardiac deaths and parental consanguinity
(Fig. 18). Blood samples were acquired from the proband, his
mother, maternal uncle and a cousin for genetic analyses.
Compound heterozygosity
Compound heterozygosity was found in the proband
expressing the risk alleles of SCN5A H558R and G98297A
polymorphisms. The presence of two risk alleles of SCN5A
may lead to variation in the INa channel formation, thus
leading to prolonged QTc in the proband. Genetic analysis of
the family members neither revealed any genetic variations
nor the same haplotype as in the proband.Table 6 e Common haplotype group e risk identification in pr
KCNQ1 S546S KCNQ1 IVS13 þ 36A > G SCN5A
A A AFamily-11
The patient, a 22 year old female was diagnosed with cLQTS
after presenting with a prolonged QTc of 475 msec. She had
been suffering with syncope from the age of 15 years (Fig. 19).
Blood samples were obtained from her parents and a 20 year
old brother along with the patient.
Compound heterozygosity
Analyses showed that the patient was carrying risk alleles for
e KCNE1 S38G, SCN5A H558R and 98297G > A polymorphisms.
The combined effect of these risk alleles may alter the func-
tioning of the IKs and INa channels.
Relatives at risk
The mother of the patient was found to carry the same
haplotype as the proband (Table 7) which include the risk
allele of SCN5A H558R and 98297G > A polymorphisms posing
the mother at risk of developing cardiac symptoms later on in
life. Predictive testing with clinical follow up could help in
preventing the onset of the disorder or may promote early
diagnosis.Family-12
The proband of this family is an 8 year old female presenting
with syncope and prolonged QTc of 490msec. Her mother hadoband's mother of family-8.
H558R SCN5A 98297G > A Identified in
G Proband, Mother
Fig. 17 e Pedigree of Family-9.
Fig. 18 e Pedigree of Family-10.
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the proband and her father were available.
Compound heterozygosity
Molecular analyses revealed that the patient was carrying
risk alleles for e SCN5A H558R and 98297G > AFig. 19 e Pedigreepolymorphisms. The effect of these risk alleles may alter
the functioning of the INa channels. It was observed that
the father of the proband did not reveal any such haplotype
or variations. Hence, it can be assumed that mother
may be a carrier but needs predictive/genetic testing
confirmation.of Family-11.
Fig. 20 e Pedigree of Family-12.
Table 7 e Common haplotype group e risk identification in proband's mother of family-11.
KCNQ1 S546S KCNQ1 IVS13 þ 36A > G SCN5A H558R SCN5A 98297G > A Identified in
G G A G Proband, Mother
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 2 6 9e2 8 5280Family-13
This family had a 10 year old female proband who presented
with symptoms of syncope since 2 years of age. She was
finally diagnosed with cLQTS after an electrocardiogram
revealed a prolonged QTc. The proband also had a family
history of consanguinity and sudden cardiac deaths of two
siblings and one cousin at a very young age (Fig. 21). Molecular
analyses were carried out on the proband, her parents and her
normal sibling.
Compound heterozygosity
The patient was found to be carrying the risk alleles for e
SCN5A H558R and 98297G > A polymorphisms. The electro-
physiology of sodium ion channel may be affected due to
these risk alleles. Parents and sibling of the proband did not
reveal any variations leading to the assumption of carrierFig. 21 e Pedigreestatus and the two siblings who had SCDs were probably
carrying the same haplotype as the proband.
Family-14
The 14 year old male proband of this family was presenting
symptoms from 11 years of age. He had episodes of syncope
and prolonged QTc of 528 msec. He did not have any signifi-
cant family history of consanguinity or sudden deaths
(Fig. 22). Blood samples were collected from proband and his
mother.
Compound heterozygosity
The patient was found to be carrying risk alleles for e KCNQ1
S546S and IVS13 þ 36A > G, SCN5A H558R and 98297G > A
polymorphisms. This genetic compound may alter the
potassium and sodium ion channels leading to prolongedof Family-13.
Fig. 22 e Pedigree of Family-14.
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u r n a l 1 5 ( 2 0 1 5 ) 2 6 9e2 8 5 281QTc. No such variations were observed in mother of the
proband. However, carrier status of the father cannot be
ruled out.
Family-15
The proband is a 10 year old female who was suffering from
episodes of syncope from 9months of age. She was diagnosed
as cLQTSwith prolongedQTc on ECG. She neither had a family
history of consanguinity or sudden deaths but her parents and
sibling's blood samples were collected for genetic analyses
(Fig. 23).
Compound heterozygosity
No variations were observed in the proband's parents but the
patientwas found to be carrying risk alleles foreSCN5AH558R
and 98297G > A polymorphisms. The presence of these risk
alleles may be altering the functioning of the sodium ion
channels.Fig. 23 e Pedigree
Table 8 e Common haplotype group e risk identification in sib
KCNE1 S38G SCN5A H558R
G ARelatives at risk
The patient's 9 years old sibling was found to carry the same
haplotype as the proband (Table 8) which include the risk
allele of SCN5A H558R and 98297G > A polymorphisms posing
the sibling at a risk of electrophysiological/ion-channel dis-
orders. Hence, follow up is necessary in such cases and pre-
dictive testing is warranted in LQTS.Family-16
The patient is a 53 year old male diagnosed with acquired
LQTS. This is a rare case expressing Dilated, Hypertrophic
cardiomyopathy and aLQTS. On being treated for cardiomy-
opathy, he presented with symptoms of syncope and pro-
longed QTc of 511 ms an indicator of aLQTS due to drugs
(Fig. 24). His treatment was altered and sample collected for
molecular analyses. None of the family members were avail-
able for sample collection.of Family-15.
ling of family-15.
SCN5A 98297G > A Identified in
G Proband and sibling
Fig. 24 e Pedigree of Family-16.
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 2 6 9e2 8 5282Compound heterozygosity
Molecular analyses of the proband revealed compound het-
erozygosity with the risk alleles being SCN5A H558R and
G98297A polymorphismss. The presence of this genetic com-
pound may have lead to the manifestation of aLQTS further
strengthening the drug responses of patients based on specific
genotypes. The study also points to the importance of phar-
macogenomics as it is observed that genetic compounds may
respond to treatment differently compared to probands with
single gene mutations.Family-17
Family-17 included a 2 year old male proband diagnosed with
aLQTS due to the ingestion of pyrethrin (mosquito repellant).
Though he did not have a family history of sudden death or
consanguinity, his parents' blood sample was collected to
identify the genetic parameters involved in the etiology of
aLQTS (Fig. 25).
Compound heterozygosity
The proband was found to be carrying risk alleles for e KCNQ1
S546S and IVS13 þ 36A > G, SCN5A H558R and 98297G > A
polymorphisms.Fig. 25 e PedigreeRelatives at risk
Both the parents of the proband were found to carry the same
haplotype as the patient (Table 9) which include the risk allele
of e KCNQ1 S546S and IVS13þ 36A > G, and SCN5A 98297G > A
polymorphisms highlighting the role of genetics in aLQTS and
the predisposition of segregating alleles in the family mem-
bers which can end up in aLQTS triggered by drugs/chemicals.
This clearly indicates pharmacogenomic relevance of alleles
to drug induced LQTS.Family-18
Family-18 had a 9 year old male cLQTS proband with a history
of syncope and consanguinity (Fig. 26). And the available
family members were the proband's mother, maternal
grandmother and grandfather.
Compound heterozygosity
The proband was found to express the risk alleles of KCNQ1
S546S, IVS13 þ 36A > G, SCN5A H558R and G98297A poly-
morphisms. The compound heterozygosity identified in the
proband could be the reason for impairment of the potassium
and sodium ion-channels leading to cLQTS. Genetic analyses
of family members neither revealed any variations nor wereof Family-17.
Table 9 e Common haplotype group e risk identification in proband's parents of family-17.
KCNQ1 S546S KCNQ1 IVS13 þ 36A > G SCN5A 98297G > A Identified in
A A G Father and Mother
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u r n a l 1 5 ( 2 0 1 5 ) 2 6 9e2 8 5 283found to carry the same haplotype as the proband. However,
history of parental consanguinity was reported thus, cLQTS
could result not only by single gene mutation but also due to
genetic compound and may act in a recessive mode.Discussion
Screening of 46 LQTS probands and their available family
members was carried out for variations in IKs, INa encoding
genes and polymorphisms in beta 1 and 2 e adrenergic re-
ceptors, tumor necrosis factor-alpha and atrial natriuretic
factor encoding genes. Of the 46 families screened, 18 have
been described above with probands revealing novel varia-
tions or compound heterozygosity. Relatives carrying the
same haplotype as the proband were also identified which
may help in predictive testing.
Families 1e4 revealed probands carrying novel variations
in KCNQ1 gene along with some risk genotypes of the above
screened genes and compound heterozygosity was identified.
The proband's parents or siblings were found to carry the
same haplotype as the proband predisposing them at a risk of
developing the ion-channel disorder later on in life. In a study
by Koo et al. [1], a spectrum ofmutations were revealed across
the coding region of KCNQ1, HERG, KCNE1, KCNE2 and SCN5A
genes in a Chinese LQTS family. Several synonymous poly-
morphisms were also identified in this LQTS family. The
possibility of some of these variants acting in concert may
predispose individuals to arrhythmias in the presence of
appropriate precipitating factors. Mutations associated with
JLN syndrome were also reported in Chinese families and
other populations [19e23].
Interestingly, three families- 5, 6 and 7 were identified as
typical cases of “anticipation” and age related penetrance in
which both mother and child were diagnosed with cLQTS. In
families- 5 and 6, the children presented with symptoms at anFig. 26 e Pedigreeearlier age but their mothers exhibited symptoms in third or
fourth decade of life. Whereas in family-7 the mother and
daughter presented with symptoms in their childhood
following which the mother was diagnosed as JLNS patient
and the daughter was identified with cLQTS. In family-6,
proband's brother and maternal uncle were carrying the
same haplotype for six alleles of various genes screened as the
proband's which may point to similar cardiac events and age
related penetrance at later stages.
Family-16 and 17 represents aLQTS probands with varia-
tions in IKs and INa encoding genes. Proband e 16 was a
typical case wherein prolonged QTc was developed due to
drugs whereas proband e 17 was a child who developed
aLQTS due to ingestion of amosquito repellant. The parents of
proband e 17 showed the same haplotype as the child
revealing the risk of developing a prolonged QTc on being
triggered by a similar event pointing to pharmacogenomic
implications.
Data point to a positive correlation between duration of the
QTc interval and probability of carrying LQTS disease-causing
mutations [2]. Hence, QTc duration was examined and it was
observed that all the patients carrying mutations had a QTc of
>480 ms. This study is in accordance with earlier reports
where LQTS infantswith disease causingmutations had a QTc
of >470 ms which could establish the genotypeephenotype
correlations as suggested by Schwartz et al. [2].
It was demonstrated that mutation carriers are at risk of
developing cardiac events even when the QTc interval is
normal [3]. Hence, in the present study, family members
harboring the variations were also predicted to be at a risk of
developing cardiac events and a follow up is therefore
warranted. Most of the families described had family
members carrying the same haplotype as the probands
indicating their risk and confirming that family screening/
predictive testing is important in identifying and manage-
ment of LQTS.of Family-18.
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 2 6 9e2 8 5284Conclusion
In the present study, FDRs carriers of the same haplotype as
the probands were predicted to be at a risk to develop cardiac
events. Hence, a follow up is therefore warranted. This es-
tablishes that family screening/predictive testing is necessary
in the identification and management of LQTS. Further, an
interesting finding is that in most of the probands exhibiting
family history were found to be genetic compounds, which
clearly points to the role of cardiac genes and their modifiers
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